CCP
TNDM icon

Clough Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History

Clough Capital Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,290
Closed -$1.05M – 152
2020
Q1 		$1.05M Sell
16,290
-49,610
-75% -$3.48M 0.1% 78
2019
Q4 		$3.93M Sell
65,900
-52,800
-44% -$3.26M 0.34% 69
2019
Q3 		$7M Sell
118,700
-30,400
-20% -$1.94M 0.58% 45
2019
Q2 		$9.62M Buy
+149,100
New +$9.62M 0.94% 41

Other funds holding TNDM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Clough Capital Partners's TNDM Position: Q2 2020 in Review

Clough Capital Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2020, closing a stake of 16,290 shares — an estimated $1.05M sold.

Clough Capital Partners first reported a position in TNDM in Q2 2019 and held it in 4 quarters. The position peaked at $9.62M in Q2 2019. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2020.

  • Clough Capital Partners reported no remaining Tandem Diabetes Care position as of Q2 2020 after selling out during the quarter.
  • Clough Capital Partners sold 16,290 Tandem Diabetes Care shares in Q2 2020, an estimated $1.05M.
  • Clough Capital Partners first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 4 quarters.
  • Clough Capital Partners's Tandem Diabetes Care position peaked at $9.62M in Q2 2019.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2020.

Based on Clough Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.